No black box warning on record for Lyumjev
As of the latest FDA labeling reviewed, Lyumjev (INSULIN LISPRO-AABC) does not carry a black box warning. Standard warnings and precautions still apply — see the full Lyumjev medicine page for the complete safety profile.